investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to RAF inhibitors
Andrew E Aplin
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Miguel Angel Zaratiegui Biurrun
The cross-regulation of host DNA replication and LTR Retrotransposons
Melanoma of skin
Cyrus Vaziri
Novel Rad18 functions in Histone Modification and Regulation of Gene Expression
Melanoma of skin
Radiation Oncology
William C Hahn
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
Melanoma of skin
Jeffrey Lee
Genetic Mechanisms of Immunity and Inflammation in Mmelanoma Progression
Melanoma of skin
Pathology
Robert J. Gillies
Causes & Consequences of Acid pH in Tumors
Melanoma of skin
Valeri Vasioukhin
Alpha-Catenin in Regulation of Tissue Homeostasis and Cancer
Melanoma of skin
Bjoern Markus Reinhard
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
Melanoma of skin
Colin B Begg
Statistical Strategies for Establishing Etiologic Heterogeneity of Tumors
Melanoma of skin
Alexander Gimelbrant
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
Melanoma of skin